10 patient recruitment for clinical trials experts
Takeda shows up three times in the careers of these patient recruitment for clinical trials experts, and the others hold recruitment titles at GSK, Pfizer, Eli Lilly and Company, Sarepta Therapeutics, AstraZeneca, Vertex Pharmaceuticals and BlueRock Therapeutics. Drug developers writing an enrollment plan, choosing recruitment partners or getting a lagging study back on schedule have someone here for each step.
Professionals to explore
Amanda Decoker
LinkedInExperience: Amanda Decoker holds Senior Director, Head of Patient Engagement, Experience and Recruitment · Takeda
$404 per 30-minute call
Amanda Decoker holds Senior Director, Head of Patient Engagement, Experience and Recruitment at Takeda since October 2025, after Senior Director, Head of Patient Recruitment and Retention (2022-2025). Amanda's other Takeda titles are Director (2021-2022) and Associate Director (2019-2021), Patient Recruitment and Retention, and Amanda was Director, Operational & Strategic Solutions at Accelerated Enrollment Solutions (2019). Ask Amanda how a patient recruitment and engagement group is organized.
Is this you? Claim your profile and get paid for calls.
Deborah Howe
LinkedInExperience: Former Director, Global Patient Recruitment and Engagement · Alexion Pharmaceuticals, Inc.
$370 per 30-minute call
Deborah Howe has been Patient Recruitment, Disease Area Lead at Vertex Pharmaceuticals since November 2024. Deborah was Director, Global Patient Recruitment and Engagement (2022-2024) and Consultant, Patient Recruitment and Engagement (2021-2022) at Alexion Pharmaceuticals, Inc., Director, Patient Recruitment at Celgene (2017-2020) and Associate Director, Therapeutic Area Lead-Specialty at Bristol Myers Squibb (2015-2017), with nearly 20 years in clinical trial recruitment. Deborah fits questions on disease-area recruitment strategy.
Is this you? Claim your profile and get paid for calls.
Jamie H. Phillips
LinkedInExperience: Former Director, Global Patient Recruitment and Retention · Arvinas
$303 per 30-minute call
Jamie H. Phillips has been Director, Patient Recruitment & Retention at BlueRock Therapeutics since September 2025, and was Director, Global Patient Recruitment and Retention at Arvinas (2023-2025). Jamie also held Patient Recruitment Lead- Contractor for Boehringer-Ingelheim (2023), Associate Director, Patient Recruitment at Pfizer (2021-2023) and Sr. Manager Patient Engagement at Biogen (2020-2021). Jamie can compare how recruitment work is set up at Pfizer, Biogen, Arvinas and BlueRock Therapeutics.
Is this you? Claim your profile and get paid for calls.
Kelly Morris
LinkedInExperience: Director of Patient Recruitment & Clinical Innovation · AstraZeneca
$370 per 30-minute call
At AstraZeneca, Kelly Morris has been Director of Patient Recruitment & Clinical Innovation since October 2024 and Patient Recruitment Lead since 2023. Kelly's other AstraZeneca titles are Global Study Associate Director (2021-2023), Global Project Manager (2020-2021) and Clinical Project Coordinator (2019-2020). Having moved from study management into recruitment at the same company, Kelly suits questions on how study teams and recruitment leads share enrollment planning.
Is this you? Claim your profile and get paid for calls.
Lauren Johnson-Dolan
LinkedInExperience: Former Recruitment and Retention Group Lead (Sr Director) · Pfizer
$404 per 30-minute call
Lauren Johnson-Dolan became Recruitment and Retention Group Lead (Sr Director) at Pfizer in June 2026, after Recruitment and Retention Team Lead (2025-2026) and Director, Participant Recruitment and Retention (2023-2025) there. Lauren also held Director (2022-2023) and Associate Director (2020-2022), Global Patient Recruitment and Retention Solutions at Seagen, and cites 20+ years in biopharma across all therapeutic areas and phases. Lauren fits questions on managing a recruitment team across many studies.
Is this you? Claim your profile and get paid for calls.
Maria Eugenia Sanchez Nozari
LinkedInExperience: Executive Director, Patient Engagement Recruitment and Retention Immunology · Eli Lilly and Company
$471 per 30-minute call
Maria Eugenia Sanchez Nozari has been Executive Director, Patient Engagement Recruitment and Retention Immunology at Eli Lilly and Company since October 2024. At Eli Lilly de Mexico, S.A. de C.V., Maria Eugenia held Executive Director - Investigator Engagement Latin America & Canada (2024), Sr Director Site Engagement-Latin America & Canada (2022-2024) and Latin America & Canada Site Engagement Director (2018-2022). Questions on investigator engagement and inclusive recruitment across regions fit Maria Eugenia.
Is this you? Claim your profile and get paid for calls.
Neha Patel Cervantes
LinkedInExperience: Director Global Patient Recruitment & Retention Programs · GSK
$370 per 30-minute call
Neha Patel Cervantes has been Director Global Patient Recruitment & Retention Programs at GSK since November 2024 and was Associate Director Feasibility and Patient Recruitment Planning there (2021-2023). Neha was Patient Recruitment Planning Manager at ICON plc (2017-2021) and Clinical Recruitment Specialist at Covance (2015-2016), and cites over 20 years in clinical research, pharmaceuticals and healthcare. Ask Neha about linking site feasibility to a recruitment plan.
Is this you? Claim your profile and get paid for calls.
Sarah Lekaditis
LinkedInExperience: Director, Patient Recruitment and Retention · Sarepta Therapeutics
$303 per 30-minute call
Sarah Lekaditis is Director, Patient Recruitment and Retention at Sarepta Therapeutics, since 2023, and since April 2026 also Director, Patient Recruitment and Start-Up Strategy there. Sarah was Associate Director, Patient Recruitment and Retention at Sarepta (2022-2023) and Senior Clinical Project Manager (2020-2022) and Clinical Project Manager (2018-2020) at Rhythm Pharmaceuticals Inc. Questions on tying site start-up to recruitment timelines fit Sarah.
Is this you? Claim your profile and get paid for calls.
Taylor B. Crush, MPH
LinkedInExperience: Sr. Director, Patient Recruitment and Engagement · Praxis Precision Medicines, Inc.
$336 per 30-minute call
Taylor B. Crush, MPH has been Sr. Director, Patient Recruitment and Engagement at Praxis Precision Medicines, Inc. since 2022, after Associate Director, Patient Recruitment and Retention at Takeda (2020-2022). Taylor held Director, Site Engagement (2014-2020), Associate Director, Site Engagement (2016-2017) and Site Engagement Lead (2016) at Continuum Clinical, A Spectrum Science Company, and describes being a global patient recruitment and retention strategist and patient advocate. Ask Taylor about site engagement and working with patient advocates.
Is this you? Claim your profile and get paid for calls.
Thresa Grady, MBA
LinkedInExperience: Director, Patient Engagement, Experience and Recruitment · Takeda
$336 per 30-minute call
Thresa Grady, MBA has been Director, Patient Engagement, Experience and Recruitment at Takeda since December 2022, managing PRR teams responsible for studies in the GI and PDT TAUs, after Patient Recruitment & Retention Lead at Takeda (2020-2022). Thresa was Senior Manager, Communications at AES/PPD (formerly Bioclinica Patient Recruitment/Retention) (2015-2020). With communications and recruitment roles, Thresa suits questions on patient-facing recruitment messaging.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For strategy across a portfolio, Maria Eugenia Sanchez Nozari (executive director for immunology), Amanda Decoker and Lauren Johnson-Dolan hold head or group lead titles, and Neha Patel Cervantes pairs feasibility with recruitment planning. Site-facing questions fit Maria Eugenia or Taylor B. Crush, who both held site engagement titles, while Sarah Lekaditis combines recruitment with study start-up strategy.
Questions to take into the conversation
- 01How do you set enrollment assumptions during feasibility, and which ones should be tested before the first site opens?
- 02When a study falls behind on enrollment, which fixes work fastest: adding sites, working with patient advocacy groups or changing outreach?
- 03How does a recruitment plan for a rare disease study with few eligible patients differ from one for a common condition?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.